Cash-pay GLP-1 care coordination

MyStart Health review

MyStart may suit someone who wants cash-pay prescribing support in one programme and can confirm the selected bill before joining. I would keep the first discount out of the ordinary monthly budget. The refund wording and contradictory branded-product cards need resolution before they become reasons to commit.

See how the program works.

Look at the support, the ongoing commitment and what the price includes.

Visit MyStart HealthOfficial provider website. No affiliate relationship is currently listed.

When it may fit

A household comparing an actual written cash-pay care quote.

  • Follow-up consultations are included in the homepage programme description.
  • Monthly and three-month purchase routes are distinguished.
  • The price-lock FAQ separates the base plan from a first-time discount.

Where it falls short

Someone choosing from a promotional saving without the renewal date and full charge.

  • The lowest displayed promotion does not establish the ordinary bill.
  • A larger supply can mean paying for a longer period.
  • Refund eligibility depends on order stage and conflicting wording.
  • Branded-product cards do not establish branded availability.
In this review

Make the ordinary bill the starting point

MyStart may make budgeting easier when clinical appointments and medicine would otherwise arrive as separate expenses. Its homepage FAQ starts the programme at $299 per month before discounts and describes prescribed medicine, clinician evaluations, follow-up, necessary blood work and shipping together. The chosen product and supply still need their own complete quote. [1]

I would write down the normal charge before looking at the holiday offer. The price-lock answer says the base plan stays the same even if the prescribed amount changes, but excludes a first-time discount. That is not a promise that an opening saving becomes the continuing bill. [1]

A three-month parcel uses a different budget

In the cost planner, separate MyStart’s monthly charges and shipments from its three-month billing option, which delivers a larger supply at once. Compared with Sprout’s annual prepayment, MyStart’s three-month option has a shorter billing term and still requires a refill intake every three months. A household choosing between them needs the cash due now and next renewal date, alongside the supply period. [1]

NativeMed shows separate introductory and continuing monthly prices, so compare the actual payments over the same period before choosing a larger first purchase. The February 2026 terms leave payment details to checkout or enrollment. Keep a copy of the selected arrangement rather than treating generic programme wording as the final invoice. [3]

The headline and the policy describe the payment differently

The homepage says there are no membership fees. The refund policy calls the purchase an all-inclusive membership, charged monthly for support whether or not medicine is prescribed. That difference needs to be settled for the selected order. Unlike Collective’s separate membership and drug charges, MyStart’s descriptions leave room for confusion about what the selected payment covers. Get that in writing before counting any item as included or extra. [1] [2]

A separate phone page has a $279 compounded-tirzepatide card against $399 without a clear card interval. It also shows Wegovy and Ozempic cards while its disclosure says those branded products are not offered. I would leave those cards out of a monthly budget until the exact purchase is explained. [4]

Read the exit before the next parcel

The cancellation FAQ allows a request through support and says medication cannot be returned. The refund policy consistently rules out refunds after shipment and for completed or partly completed membership periods. Stopping a later renewal is different from reclaiming the cost of a parcel already sent. [1] [2]

An earlier cutoff is less clear: the policy allows pre-fulfillment cancellation, but also lists a written prescription as nonrefundable. Its specific medical-ineligibility exception requires no prescription and no shipment. I would obtain the applicable cutoff before paying instead of assuming cancel-anytime means a risk-free first order. [2]

Support is useful when responsibility is clear

MyStart describes clinician contact without an additional consultation charge in its programme FAQ. It identifies independent clinicians and pharmacies as the people responsible for care and dispensing, while the platform coordinates access. The practical question is whether the actual arrangement connects a reader to the right person when an order or care concern arises. [1]

The compounds are not FDA-approved. FDA’s September 2025 advertising warning concerned equivalence claims for compounded semaglutide; it was not a contamination test or a finding about this reader’s outcome. Later resolution is not established here. A familiar medicine name should not erase the distinction between preparations. [5] [6]

Pay for support you will use

The homepage qualifies its results with a sixteen-customer survey and says individual outcomes are not typical. Those stories do not show that joining the programme will produce the same change in an ordinary household. A service needs to earn its place through the care and support it actually supplies. [1]

MyStart is worth comparing after the recurring purchase and exit are clear. Found offers a separate clinical and behavioral arrangement to assess; it has its own scope and commitment. Choose the support that fits the week and the budget, with the prescription decision left to an appropriate clinician.

Understanding the cost

Homepage FAQ starts the programme at $299/month before discounts and describes monthly or three-month renewal. Actual selected medicine, supply, promotion and recurring total require a written quote. Separate phone page advertises compounded tirzepatide $279 against $399 without a clear card interval; do not treat that as a monthly complete-care price. Brand-name cards conflict with that page’s express no-Wegovy/no-Ozempic disclosure. Refund cutoff wording conflicts between prescription issuance and fulfillment/shipment. [1] [2] [3] [4]

Build your cost estimate

Sources

  1. MyStart: programme pricing, renewals and independent-care disclosures
  2. MyStart: December 1, 2025 refund and fulfillment policy
  3. MyStart: February 1, 2026 terms and payment scope
  4. MyStart: public phone-offer cards and brand-name exclusion
  5. FDA: September 9, 2025 MyStart advertising warning
  6. MyStart: compounded-product and results disclosures

This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.

Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.